Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

Basic information Safety Supplier Related

ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate Basic information

Product Name:
ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
Synonyms:
  • ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
  • 3-b]pyridine-2-carboxylate
  • ethyl 4-broMo-1H-pyrrolo[2
  • ethyl 6-chloro-1H-pyrrolo[2
  • 1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 4-broMo-, ethyl ester
  • Ethyl 4-Bromo-7-azaindole-2-carboxylate
CAS:
942920-55-0
MF:
C10H9BrN2O2
MW:
269.09
Product Categories:
  • Heterocycle-Pyridine series
  • CHIRAL CHEMICALS
Mol File:
942920-55-0.mol
More
Less

ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate Chemical Properties

Density 
1.624±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
10.96±0.40(Predicted)
Appearance
White to off-white Solid
InChI
InChI=1S/C10H9BrN2O2/c1-2-15-10(14)8-5-6-7(11)3-4-12-9(6)13-8/h3-5H,2H2,1H3,(H,12,13)
InChIKey
VLZWUULVFAASBC-UHFFFAOYSA-N
SMILES
C12NC(C(OCC)=O)=CC1=C(Br)C=CN=2
More
Less

ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate Usage And Synthesis

Uses

Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate is used in pharmaceutical synthesis and experiments.

Synthesis

287384-82-1

942920-55-0

Step A: Synthesis of ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate Ethyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate-7-oxide (1 g, 5 mmol) (prepared according to the method disclosed in WO 2000/044753, see Example 6, Step C) was added to a suspension of tetramethylammonium bromide (1.2 g, 7.5 mmol) in N,N-dimethylformamide (50 mL). The reaction mixture was cooled to 0 °C, followed by batchwise addition of methylsulfonic anhydride (1.7 g, 10 mmol). The mixture was warmed to room temperature and stirring was continued for 6 hours. Upon completion of the reaction, the mixture was poured into water (100 mL) and neutralized with 50% aqueous sodium hydroxide solution. The aqueous phase was extracted with ethyl acetate and the organic layer was washed sequentially with brine and deionized water. The organic phase was concentrated under reduced pressure to give the crude product. Purification by SCX column chromatography afforded ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate as a light yellow solid (1 g, 77% yield). 1H NMR (400MHz, DMSO-d6) δ ppm: 1.35 (t, 3H, J=7.1Hz), 4.36 (q, 2H, J=7.1Hz), 7.05 (d, 1H, J=2.0Hz), 7.48 (d, 1H, J=5.1Hz), 8.28 (d, 1H, J=5.1Hz), 12.95 (brs , 1H).

References

[1] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3973 - 4001
[2] Patent: WO2008/49855, 2008, A2. Location in patent: Page/Page column 54
[3] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 16, p. 4610 - 4614
[4] Patent: US2009/18156, 2009, A1. Location in patent: Page/Page column 18-19
[5] Patent: WO2007/76423, 2007, A2. Location in patent: Page/Page column 96

ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylateSupplier

Xi 'an fanta biotechnology co., LTD Gold
Tel
19929974101 //1144079830; 19929974101
Email
1144079830@qq.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
Shangchem Co., Ltd.
Tel
+86-21-68182121
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com